Ardent Health Partners ARDT Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 97.5%-0.1pp | 97.5%0.0pp | 97.6%+0.1pp | 97.6%+0.1pp | 97.6%+0.1pp | |
| Net margin | 2.1%-1.6pp | 2.1%-1.4pp | 3.2%+1.6pp | 4.1%+2.5pp | 3.7%+2.3pp | |
| Returns | ||||||
| Return on equity | 10.7%-9.0pp | 11.2%-12.1pp | 18.3%+9.1pp | 25.6%— | 19.7%— | |
| Return on invested capital | 14.6%— | —— | —— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 1.3×— | —— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 2.1×0.0× | 2×— | 2.1×— | 2.1×— | 2.1×— | |
| Leverage | ||||||
| Debt-to-equity | 0.9×-0.1× | 1.8×— | 0.9×— | 0.9×— | 1×— | |
| Net debt / EBITDA | 1.1×0.0× | 3.3×— | 1×— | 1×— | 1.1×— | |
| Per Share | ||||||
| Book value per share | $9.43+12.9% | $9.11+6.8% | $8.77+19.9% | $8.87+51.1% | $8.35-5.1% | |
| Valuation | ||||||
| Market capitalization | $1.35B-27.8% | $1.26B— | $1.9B— | —— | —— | |
| Price / earnings | 10×+1.7× | 9.3×— | 9.2×— | —— | —— | |
| Price / sales | 0.2×-0.1× | 0.2×— | 0.3×— | —— | —— | |
| Price / book | 1×-0.6× | 1×— | 1.5×— | —— | —— | |
| EV / EBITDA | 3.8×-0.5× | 5.9×— | 4.3×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Ardent Health Partners's ratios come from?
- Every ratio is computed from Ardent Health Partners's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
